Accepted for/Published in: JMIR Research Protocols
Date Submitted: Apr 27, 2022
Date Accepted: Jun 16, 2022
Date Submitted to PubMed: Oct 13, 2022
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
A telepsychiatry approach for COVID-19+ patients and family members during and after hospitalization: the DigiCOVID trial protocol
ABSTRACT
Background:
The COVID-19 pandemic is negatively impacting the mental health of both COVID-19 patients and the general population. Given the current guidelines limiting in person contact to reduce the spread of the virus, a digital approach is needed to tackle the psychological aftermath of the pandemic. Here, we present DigiCOVID, a digital mental health approach to offer remote, personalized support to former or current COVID-19 patients and/or their relatives.
Objective:
The main goal of this project is to evaluate the feasibility, acceptability and usability of DigiCOVID. Furthermore, as we have designed DigiCOVID in order to improve mental wellbeing, we also aim to assess the impact of the abovementioned intervention by means of pre-post changes in psychological clinical variables.
Methods:
Participants undergo an initial phone-based screening to ensure inclusion criteria are met. Then, they complete a neuropsychological test over video to assess IQ, and fill out online self-reports of health and wellbeing. Participants are then assigned to psychotherapist who offers 8 tele-therapy sessions. At the end of the therapy cycle, the online questionnaires are filled out again.
Results:
As of April 2022, we enrolled a total of 122 subjects, of which 94 have completed neuropsychological tests and online questionnaires.
Conclusions:
Our study aims at testing the feasibility and preliminary efficacy of DigiCOVID, a remote tele-psychiatry approach to tackle the COVID-19 pandemic psychological aftermaths. To date, the approach used seems to be feasible and highly customizable to patients’ needs, and thus DigiCOVID could provide a blueprint for future tele-psychiatry-based interventions. Clinical Trial: This study was approved by our local Ethics Committee (IRCCS Ca’ Granda Ospedale Maggiore Policlinico) on 28.10.2020. The trial is registered on clinicaltrials.gov with the following ID: NCT05231018.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.